However, the local administration of an anti-vimentin neutralizing monoclonal antibody (mAb) was able to suppress the periodontal bone loss induced by the attachment of a ligature, suggesting that CV is a potential target for the development of diagnostic and therapeutic approaches for periodontitis. The gene discussed is VIM; the disease is periodontitis.